Current Issue
Volumes and Issues
For Authors
Manuscript Guidelines
Review Process
Conflict of Interest
Copyright
About the Journal
Editorial Board
Aim and Scope
Policy and Ethical Guidelines
Promotion of the Journal
Print-Version Subscription
Publisher and Contact Information
Contact Information
Sign in as an AUTHOR/REVIEWER
REVIEW PAPER
CLINICAL ROLE OF miRNA BIOMARKERS IN LARYNGEAL SQUAMOUS CELL CARCINOMA (LSCC): LITERATURE REVIEW
1
Student Scientific Club at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Poland
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
Submission date: 2023-02-23
Final revision date: 2023-07-19
Acceptance date: 2023-07-21
Online publication date: 2023-12-22
Publication date: 2023-12-22
Corresponding author
Barbara Rusinowska
Student Scientific Club at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Radziwiłłowska 11, 20-080, Lublin, Poland
Student Scientific Club at the Department of Epidemiology and Clinical Research Methodology, Medical University of Lublin, Radziwiłłowska 11, 20-080, Lublin, Poland
J Hear Sci 2023;13(4):9-16
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Malignant transformations may result from gene dysregulation caused by genetic and epigenetic modifications. The use of miRNAs to treat cancer depends on the downregulation or upregulation of the miRNAs responsible for carcinogenesis (proliferation, angiogenesis, invasion, metastasis), providing the opportunity to suppress tumors. The purpose of this review is to list miRNAs identified so far as biomarkers in laryngeal squamous cell carcinoma (LSCC). This listing may help in predicting the evolution of miRNAs and developing anti-miRNAs and miRNA-mimics as anti-cancer therapies.
Material and methods:
Relevant publications from 2008 to 2022 were retrieved from the PubMed and Google Scholar databases, using the key words miRNA (PubMed – 149,294 results; Google Scholar – 205,000 results), laryngeal squamous cell carcinoma (PubMed – 33,191 results; Google Scholar – 17,900 results), laryngeal squamous cell carcinoma biomarkers (PubMed – 6249 results; Google Scholar – 18,000 results), laryngeal squamous cell carcinoma miRNA (PubMed – 1338 results; Google Scholar – 17,500 results). Eventually 51 papers were selected for review.
Results:
We identified 51 studies which have detected miRNA-based biomarkers for LSCC, and they are broadly reviewed here.
Conclusions:
The identified laryngeal squamous cell-specific miRNA biomarkers appear to be promising for the detection, predicted course, and treatment of LSCC.
Malignant transformations may result from gene dysregulation caused by genetic and epigenetic modifications. The use of miRNAs to treat cancer depends on the downregulation or upregulation of the miRNAs responsible for carcinogenesis (proliferation, angiogenesis, invasion, metastasis), providing the opportunity to suppress tumors. The purpose of this review is to list miRNAs identified so far as biomarkers in laryngeal squamous cell carcinoma (LSCC). This listing may help in predicting the evolution of miRNAs and developing anti-miRNAs and miRNA-mimics as anti-cancer therapies.
Material and methods:
Relevant publications from 2008 to 2022 were retrieved from the PubMed and Google Scholar databases, using the key words miRNA (PubMed – 149,294 results; Google Scholar – 205,000 results), laryngeal squamous cell carcinoma (PubMed – 33,191 results; Google Scholar – 17,900 results), laryngeal squamous cell carcinoma biomarkers (PubMed – 6249 results; Google Scholar – 18,000 results), laryngeal squamous cell carcinoma miRNA (PubMed – 1338 results; Google Scholar – 17,500 results). Eventually 51 papers were selected for review.
Results:
We identified 51 studies which have detected miRNA-based biomarkers for LSCC, and they are broadly reviewed here.
Conclusions:
The identified laryngeal squamous cell-specific miRNA biomarkers appear to be promising for the detection, predicted course, and treatment of LSCC.
REFERENCES (51)
1.
Baird BJ, Sung CK, Beadle BM, Divi V. Treatment of early-stage laryngeal cancer: a comparison of treatment options. Oral Oncol, 2018; 87: 8–16. https://doi.org/10.1016/j.oral....
2.
Zhang Y, Li W, Wang Y, Wang N. The PLCE1 rs2274223 variant is associated with the risk of laryngeal squamous cell carcinoma. Int J Med Sci, 2020; 17(17): 2826–30. https://doi.org/10.7150/ijms.4....
3.
Wronkiewicz SK, Roggli VL, Hinrichs BH, Kendler A, Butler RA, Christensen BC et al. Chrysotile fibers in tissue adjacent to laryngeal squamous cell carcinoma in cases with a history of occupational asbestos exposure. Mod Pathol, 2020; 33(2): 228–34. https://doi.org/10.1038/s41379....
4.
Seebauer CT, Hackenberg B, Grosse J, Rennert J, Jung EM, Ugele I et al. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma: a review. Strahlenther Onkol, 2021; 197(3): 167–76. https://doi.org/10.1007/s00066....
5.
Forsyth AM, Camilon PR, Tracy L, Levi JR. Pediatric laryngeal tumors and demographics, management, and survival in laryngeal squamous cell carcinoma. Int J Pediatr Otorhinolaryngol, 2021; 140: 110507. https://doi.org/10.1016/j.ijpo....
6.
Wong TS, Gao W, Li ZH, Chan JY, Ho WK. Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol, 2012; 2012: 739461. https://doi.org/10.1155/2012/7....
7.
Arens C, Schwemmle C, Voigt-Zimmermann S. [Surgical reconstruction in laryngeal carcinoma]. HNO, 2020; 68(9): 666–77 [in German]. https://doi.org/10.1007/s00106....
8.
Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc, 2008; 83(4): 489–501. https://doi.org/10.4065/83.4.4....
9.
Paget-Bailly S, Cyr D, Luce D. Occupational exposures and cancer of the larynx: systematic review and meta-analysis. J Occup Environ Med, 2012; 54(1): 71–84. https://doi.org/10.1097/JOM.0b....
10.
Zhou J, Zhang D, Yang Y, Zhou L, Tao L. Association between Helicobacter pylori infection and carcinoma of the larynx or pharynx. Head Neck, 2016; 38(1): E2291-6. https://doi.org/10.1002/hed.24....
11.
Lei DP, Pan XL. [Treatment options for advanced laryngeal carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2019; 54(5): 398–400 [in Chinese]. https://doi.org/10.3760/cma.j.....
12.
Adeel M, Faisal M, Rashid A, Usman S, Khaleeq U, Abbas T et al. An overview of laryngeal cancer treatment at a tertiary care oncological center in a developing country. Cureus, 2018; 10(6): e2730. https://doi.org/10.7759/cureus....
13.
Mattioli F, Fermi M, Molinari G, Capriotti V, Melegari G, Bertolini F et al. pT3 N0 laryngeal squamous cell carcinoma: oncologic outcomes and prognostic factors of surgically treated patients. Laryngoscope, 2021; 131(10): 2262–8. https://doi.org/10.1002/lary.2....
14.
Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech, 2021; 14(4): dmm047662. https://doi.org/10.1242/dmm.04....
15.
de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M. Deciphering miRNAs’ action through miRNA editing. Int J Mol Sci, 2019; 20(24): 6249. https://doi.org/10.3390/ijms20....
16.
Peng YH, Yang WF, Lu SW, Lan XB, Peng SP. [Mechanism research progress of miRNA in laryngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2017; 31(14): 1134–9 [in Chinese].
https://doi.org/10.13201/j.iss....
17.
Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev, 2015; 87: 3–14. https://doi.org/10.1016/j.addr....
18.
Tétreault N, De Guire V. miRNAs: their discovery, biogenesis and mechanism of action. Clin Biochem, 2013; 46(10–11): 842–5. https://doi.org/10.1016/j.clin....
19.
Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics, 2019; 11(1): 25. https://doi.org/10.1186/s13148....
20.
Bourassa MW, Ratan RR. The interplay between microRNAs and histone deacetylases in neurological diseases. Neurochem Int, 2014; 77: 33–9. https://doi.org/10.1016/j.neui....
21.
Forterre A, Komuro H, Aminova S, Harada M. A comprehensive review of cancer microRNA therapeutic delivery strategies. Cancers (Basel), 2020; 12(7): 1852. https://doi.org/10.3390/cancer....
22.
Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol, 2018; 141(4): 1202–7. https://doi.org/10.1016/j.jaci....
23.
Inoue J, Inazawa J. Cancer-associated miRNAs and their therapeutic potential. J Hum Genet, 2021; 66(9): 937–45. https://doi.org/10.1038/s10038....
24.
Chen Y, Gao DY, Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv Drug Deliv Rev, 2015; 81: 128–41. https://doi.org/10.1016/j.addr....
25.
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ et al. The microRNA spectrum in 12 body fluids. Clin Chem, 2010; 56(11): 1733–41. https://doi.org/10.1373/clinch....
26.
Tang YT, Huang YY, Zheng L, Qin SH, Xu XP, An TX et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med, 2017; 40(3): 834–44. https://doi.org/10.3892/ijmm.2....
27.
Wright K, de Silva K, Purdie AC, Plain KM. Comparison of methods for miRNA isolation and quantification from ovine plasma. Sci Rep, 2020; 10(1): 825. https://doi.org/10.1038/s41598....
28.
Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release, 2013; 172(3): 962–74. https://doi.org/10.1016/j.jcon....
29.
Ding D, Qi Z. Clinical significance of miRNA-195 expression in patients with laryngeal carcinoma. J BUON, 2019; 24(1): 315–22.
30.
Li P, Liu H, Wang Z, He F, Wang H, Shi Z et al. MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy. Am J Transl Res, 2016; 8(5): 1935–44.
31.
Grzelczyk LW, Szemraj J, Kwiatkowska S, Józefowicz-Korczyńska M. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC). Diagn Pathol, 2019; 14(1): 49. https://doi.org/10.1186/s13000....
32.
Hu Y, Liu H. MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation. Eur Arch Otorhinolaryngol, 2015; 272(2): 391–9. https://doi.org/10.1007/s00405....
33.
Falco M, Tammaro C, Takeuchi T, Cossu AM, Scafuro G, Zappavigna S, et al. Overview on molecular biomarkers for laryngeal cancer: looking for new answers to an old problem. Cancers (Basel), 2022; 14(7): 1716. https://doi.org/10.3390/cancer....
34.
Chen L, Sun DZ, Fu YG, Yang PZ, Lv HQ, Gao Y, et al. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway. Cell Signal, 2020; 66: 109444. https://doi.org/10.1016/j.cell....
35.
Gao, S., Wang, J., Xie, J. et al. Role of miR-138 in the regulation of larynx carcinoma cell metastases. Tumor Biol, 2016; 37: 15601–6. https://doi.org/10.1007/s13277....
36.
Zhao X, Zhang W, Ji W. MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma. Onco Targets Ther, 2018; 11: 3619–35. https://doi.org/10.2147/OTT.S1....
37.
Yu CH, Xing FY, Zhang JY, Xu JQ, Li YC. A combination of mRNA expression profile and miRNA expression profile identifies detection biomarkers in different tumor stages of laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci, 2018; 22(21): 7296–304. https://doi.org/10.26355/eurre....
38.
Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M, et al. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol, 2014; 35(6): 5953–63. https://doi.org/10.1007/s13277....
39.
Gao W, Wu Y, He X, Zhang C, Zhu M, Chen B, et al. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1. J Cancer, 2017; 8(12): 2356–68. https://doi.org/10.7150/jca.19....
40.
Zhang F, Cao H. MicroRNA 143 3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k Ras/Raf/MEK/ERK signaling pathway. Int J Oncol, 2019; 54(2): 689–701. https://doi.org/10.3892/ijo.20....
41.
Xu Y, Lin YP, Yang D, Zhang G, Zhou HF. Clinical significance of miR-149 in the survival of patients with laryngeal squamous cell carcinoma. Biomed Res Int, 2016; 2016: 8561251. https://doi.org/10.1155/2016/8....
42.
Shuang Y, Li C, Zhou X, Huang Y, Zhang L. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1. Oncol Rep, 2017; 38(4): 2155–65. https://doi.org/10.3892/or.201....
43.
Liu Y, Liu J, Wang L, Yang X, Liu X. MicroRNA 195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1. Mol Med Rep, 2017; 16(5): 7154–62. https://doi.org/10.3892/mmr.20....
44.
Pang H, Xu X, Dai L, Wang K, Yao X. MicroRNA 195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma. Mol Med Rep, 2018; 17(4): 5283–91. https://doi.org/10.3892/mmr.20....
45.
Li JZ, Gao W, Lei WB, Zhao J, Chan JY, Wei WI, et al. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Oncotarget, 2016; 7(36): 58218–33. https://doi.org/10.18632/oncot....
46.
Dioguardi M, Spirito F, Sovereto D, Alovisi M, Aiuto R, Garcovich D, et al. The prognostic role of miR-31 in head and neck squamous cell carcinoma: systematic review and meta-analysis with trial sequential analysis. Int J Environ Res Public Health, 2022; 19(9): 5334. https://doi.org/10.3390/ijerph....
47.
Yang S, Wang J, Ge W, Jiang Y. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31. J Cell Biochem, 2018; 119(8): 6953–60. https://doi.org/10.1002/jcb.26....
48.
Ma J, Hu X, Dai B, Wang Q, Wang H. Prediction of the mechanism of miRNAs in laryngeal squamous cell carcinoma based on the miRNA-mRNA regulatory network. PeerJ, 2021; 9: e12075. https://doi.org/10.7717/peerj.....
49.
Re M, Magliulo G, Gioacchini FM, Bajraktari A, Bertini A, Çeka A, et al. Expression levels and clinical significance of miR-21-5p, miR-let-7a, and miR-34c-5p in laryngeal squamous cell carcinoma. Biomed Res Int, 2017; 2017: 3921258. https://doi.org/10.1155/2017/3....
50.
Janiszewska J, Szaumkessel M, Kostrzewska-Poczekaj M, Bednarek K, Paczkowska J, Jackowska J, et al. Global miRNA expression profiling identifies miR-1290 as novel potential oncomiR in laryngeal carcinoma. PLoS One, 2015; 10(12): e0144924. https://doi.org/10.1371/journa....
51.
Li M, Tian L, Wang L, Yao H, Zhang J, Lu J, Sun Y, Gao X, Xiao H, Liu M. Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC. PLoS One, 2013; 8(10): e77829. https://doi.org/10.1371/journa....
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
